Tronox (OTCMKTS: TROX) and PURE Bioscience (OTCMKTS:PURE) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.


This table compares Tronox and PURE Bioscience’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tronox N/A N/A N/A
PURE Bioscience -388.83% -210.88% -128.61%

Analyst Ratings

This is a summary of current ratings and recommmendations for Tronox and PURE Bioscience, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tronox 0 0 4 0 3.00
PURE Bioscience 0 0 0 0 N/A

Tronox currently has a consensus price target of $27.67, suggesting a potential upside of Infinity. Given Tronox’s higher probable upside, equities research analysts plainly believe Tronox is more favorable than PURE Bioscience.

Valuation and Earnings

This table compares Tronox and PURE Bioscience’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tronox N/A N/A N/A N/A N/A
PURE Bioscience $1.83 million 34.96 -$6.26 million ($0.11) -8.55

Tronox has higher earnings, but lower revenue than PURE Bioscience.

Insider and Institutional Ownership

0.2% of PURE Bioscience shares are held by institutional investors. 10.6% of PURE Bioscience shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.


Tronox beats PURE Bioscience on 5 of the 8 factors compared between the two stocks.

Tronox Company Profile

Tronox Limited is engaged in production and marketing of titanium bearing mineral sands and titanium dioxide pigment (TiO2). The Company’s TiO2 products are critical components of everyday applications, such as coatings, plastics, paper and other applications. The Company’s mineral sands business consists primarily of two product streams: titanium feedstock and zircon. The Company operates in three segments: mineral sands, pigment and corporate and other. The corporate and other include its electrolytic manufacturing business. It has operations in North America, Europe, South Africa and the Asia-Pacific region. The Company operates three TiO2 facilities at the locations in Hamilton, Mississippi, Botlek, The Netherlands, and Kwinana, Western Australia, representing approximately 465,000 tons of annual TiO2 production capacity.

PURE Bioscience Company Profile

PURE Bioscience, Inc. is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company’s technology platform is based on stabilized ionic silver and its products contain silver dihydrogen citrate (SDC). It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains and food processors. It is testing and continuing development of PURE Control to utilize PURE Control as a direct food contact processing aid for raw meats, including beef and pork. In addition to PURE Hard Surface and PURE Control, it manufactures and sells SDC-based products for end use; products preserved with SDC, and SDC as a raw material ingredient for manufacturing use. These products include PURE Multi-Purpose and Floor Cleaner Concentrate, PURE Multi-Purpose Hi-Foam Cleaner Concentrate, Axen 30, Axenohl and SILVERION.

Receive News & Ratings for Tronox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tronox and related companies with's FREE daily email newsletter.